Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ministry Of Health Labor And Welfare
Pharma
After FDA says no on Dupixent for hives disorder, Japan says yes
Four months after the FDA rejected Sanofi and Regeneron’s Dupixent to treat CSU, Japan has signed off on the treatment in the indication.
Kevin Dunleavy
Feb 16, 2024 10:54am
Regeneron-Sanofi's Praluent gets Japan MHLW nod
Jul 5, 2016 9:29am
Japan reshuffles key posts at MHLW
Jun 20, 2016 7:54am
Sanofi gets Japan nod for alirocumab
Jun 6, 2016 12:06am
